Part of Medtronic Plc, Covidien Pte Ltd. is a Singaporean company located in Singapore that manufactures and supplies medical equipment.

Acclarent, Inc. is a medical device company in Menlo Park, CA that was established in June of 2004. The company is dedicated to the development of innovative devices providing new technologies to further meet the needs of ENT patients. Acclarent's initial focus is on achieving the goals of sinus surgery with novel, endoscopic, catheter-based tools - Balloon Sinuplastyâ„¢ devices. Through the Balloon Sinuplastyâ„¢ technology and our RelievaÂ:registered: product portfolio we offer ENT patients alternatives to conventional endoscopic surgical approaches. FDA clearances for these devices were completed in 2005 and the products were commercially launched in the US that same year. Through our core technologies and commitment to innovation, Acclarent will continue to advance novel devices in all areas of ENT.

Cellatoz Therapeutics with the goal of resolving the unmet medical needs of incurable diseases. Korea's top R & D specialists gather to discover differentiated therapeutic cell and platform technologies, and promote the commercialization of cell therapy products based on the company's intermediary research and product development capabilities.Cellatoz Therapeutics are the first in the world to acquire musculoskeletal stem cell (MSSC) induction technology capable of final differentiation from embryonic stem cells and inducible pluripotent stem cells (iPSC) into mesodermal tissue cells. By modulating the cell differentiation signals of the cells, we are developing a therapeutic agent for musculoskeletal-related diseases (eg compound fracture, arthritic cartilage damage, etc.) that can regenerate and repair the tissue of the musculoskeletal injured area.

Intersect ENT, Inc. is a commercial drug delivery company, which engages in the treatment of ear, nose, and throat conditions. Its products include PROPEL and SINUVA. The PROPEL used to maintain the opening and locally deliver steroid after sinus surgery. The SINUVA is used to treat adult patients with ethmoid sinus surgery yet suffer from recurrent sinus obstruction due to polyps. The company was founded by Donald J. Eaton in October 2003 and is headquartered in Menlo Park, CA.

ArthroCare develops and manufactures surgical devices, instruments, and implants that strive to enhance surgical techniques as well as improve patient outcomes. Its devices improve many existing surgical procedures and enable new minimally invasive procedures. Many of ArthroCare's devices use its internationally patented Coblation (R) technology. This technology precisely dissolves target tissue and limits damage to surrounding healthy tissue. ArthroCare also develops surgical devices utilizing other patented technology including its OPUS (R) line of fixation products as well as re-usable surgical instruments. ArthroCare is leveraging these technologies in order to offer a comprehensive line of surgical devices to capitalize on a multi-billion dollar market opportunity across several surgical specialties, including its two core product areas consisting of Sports Medicine and Ear, Nose, and Throat as well as other areas such as spine, wound care, urology and gynecology.

Somnus Medical Technologies, Inc. designs, develops, manufactures, and markets medical devices that utilize its proprietary radio frequency technology for the treatment of upper airway disorders. The Company's "Somnoplasty System" provides physicians with a suite of products which offer minimally-invasive, curative treatment alternatives for snoring, and other disorders of the upper airway. Source-Bloomberg-http://www.bloomberg.com/quote/SOMN:US/profile

AntiCancer, Inc. operates as a biotechnology company. It develops drugs for cancer based on genetic engineering and targeting cancer specific metabolic defects. The company provides Oncobriteâ, a small-animal imaging technology; MetaMouseâ and ANGIOMOUSEâ that are mouse models of human cancer; Histoculture Drug Response Assay, an individualized cancer therapy; Oncase-PEGâ, a recombinant protein that depletes methionine in tumors; stem cells for general regenerative medicine; tumor-targeting bacteria; and Dermatek, a liposome-based hair-follicle targeting technology. It also offers Enzymatic Homocysteine, Enzymatic B6, and Enzymatic cysteine assays.

Behringwerke AG, a subsidiary of Sanofi, is a German company located in Marburg. The firm produces specialty chemicals and pharmaceutical products.

Carcidiag Biotechnologies develops a diagnostic, fast, sensitive, specific and innovative tool for the detection of precancerous cells for the prevention of carcinogenesis affecting the ENT sphere (tongue, pharynx, oral mucosa), the colorectal area and the lungs as well as the gynecological cancers.

Teijin Ltd. engages in the management of its group companies that are involved in the environment and energy, safety and protection, information and electronics, transportation, and healthcare businesses. It operates through the following segments: Materials, Healthcare, and Others. The Materials segment handles the manufacture and sale of polyester, aramid, and carbon fiber products as well as plastic and resin products from polycarbonate resin and polyester film. The Healthcare segment deals with the manufacture and sale of pharmaceuticals and home medical equipment. It also provides home healthcare services. The Others segment offers information technology services. The company was founded by Seita Kumura, Itsuzo Hata, and Naokichi Kaneko on June 17, 1918 and is headquartered in Osaka, Japan.

Medtronic Xomed, Inc. manufactured and distributed surgical products. It offered powered tissue-removal systems, microendoscopy instruments, implantable devices, nerve monitoring systems, disposable fluid-control metal, and image-guided surgery system products. The company was headquartered in Jacksonville, FL.

Part of Medtronic Plc, Medtronic Advanced Energy LLC is a company headquartered in the United States that develops and markets surgical products.

US Agriculture LLC provides investment services. It operates and manage farmland assets and portfolios, develop and implement farmland investment strategies, underwrite and acquire farmland assets across a variety of regions and crop types, develop and implement efficient and effective reporting processes, design and implement investment policies, develop and implement asset allocation strategies, create and implement tools for market and asset targeting, and create and implement portfolio optimization tools and processes. The company was founded in 2015 and is headquartered in Indianapolis, IN.

UAB Research Foundation (doing business as UABRF), a subsidiary of The University of Alabama System, is a company headquartered in Birmingham, AL. The firm engages in identify, assess, and market commercially viable technology developed at The University of Alabama at Birmingham.

Provides research and development services for pharmaceutical preparations

PEAK Surgical is a medical device company that has developed the PEAK Surgery System, a new tissue dissection system based on a proprietary technology that represents an important advance in radiofrequency surgical technologies. The PEAK Surgery System consists of the PEAK PlasmaBlade, a family of disposable cutting devices that offer the exacting control of a scalpel and the bleeding control of traditional electrosurgery without extensive collateral damage, and the PULSAR Generator, which supplies pulsed plasma radiofrequency energy to the PlasmaBlade. The PEAK Surgery System is cleared for use in general, plastic and reconstructive, ENT, gynecologic, orthopedic, arthroscopic, spinal and neurological surgical procedures in the United States, and for use in general surgery in the European Union. It was launched in the United States in July 2008 and has been used by U.S. surgeons on many patients, including general, gynecologic, orthopedic and plastic and reconstructive surgeries

Manufactures and wholesales medical devices

LINDA AG engages in supply of pharmaceutical products. It offers green linda and ovivo products. The company was headquartered in Cologne, Germany.

The 301 Hospital (Chinese: 三〇一医院) or People's Liberation Army General Hospital (Chinese: 中国人民解放军总医院), which constitutes simultaneously the PLA Postgraduate Medical School (Chinese: 中国人民解放军医学院), located in Beijing, China, is a military hospital directly subsidiary to Logistic Support Department of the Central Military Commission and the largest general hospital under the auspices of the People's Liberation Army. Its mission includes assuring the health of PLA and China's leaders.